Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01414595 · ClinicalTrials.gov registry record
Study of Tissue Samples From Patients With Non-Small Cell Lung Cancer
A clinical trial, sponsored by Alliance for Clinical Trials in Oncology.
- Completed
- Registry status
- 248
- Enrollment target
NCT01414595: Completed study, sponsored by Alliance for Clinical Trials in Oncology.
NCT01414595 is a clinical trial that has completed, run by Alliance for Clinical Trials in Oncology. The registered enrollment target is 248 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01414595 has completed, sponsored by Alliance for Clinical Trials in Oncology.
- COMPLETED
- Registry status
- 248 participants
- Enrollment target
Study Summary
RATIONALE: Studying samples of tissue from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. PURPOSE: This research trial studies tissue samples from patients with non-small cell lung cancer.
Interventions
- GENETIC gene expression analysis
- GENETIC DNA analysis
- GENETIC RNA analysis
- GENETIC DNA methylation analysis
- GENETIC polymorphism analysis
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 248 participants |
| Start Date | 2012-03 |
What the finished NCT01414595 record still lists
NCT01414595 is an observational study that tracks outcomes without assigning an intervention. The registered 248 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 5 interventions - of which gene expression analysis is the first listed.
NCT01414595 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01414595 about?
NCT01414595 is a clinical study titled "Study of Tissue Samples From Patients With Non-Small Cell Lung Cancer". RATIONALE: Studying samples of tissue from patients with cancer in the laboratory may help doctors learn more about changes that occur in DNA and identify biomarkers related to cancer. PURPOSE: This research trial studies tissue samples from patients with non-small cell lung cancer.
What is the current status of trial NCT01414595?
This trial is currently completed. The enrollment target is 248 participants. The study started on 2012-03.
What interventions are being tested in trial NCT01414595?
The interventions under investigation include: gene expression analysis (GENETIC), DNA analysis (GENETIC), RNA analysis (GENETIC), DNA methylation analysis (GENETIC), polymorphism analysis (GENETIC).
Who is sponsoring clinical trial NCT01414595?
This trial is sponsored by Alliance for Clinical Trials in Oncology, which has 446 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT04577911 · 248 participants
How is Social Connection Represented in the Brain?
- NCT04777994 · 248 participants · Phase 1
Study With ABBV-CLS-484 in Participants With Locally Advanced or Metastatic Tumors
- NCT04792489 · 248 participants · Phase 2
DALY II USA/ MB-CART2019.1 for DLBCL
- NCT04830137 · 248 participants · Phase 1
A Study of NX-2127 in Adults With Relapsed/Refractory B-cell Malignancies
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia